Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas E Gladstone

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Current Opinion in Oncology|December 21, 2010
High-dose chemotherapy and multiple sclerosisDaniel Harrison, Douglas E Gladstone
Current Opinion in Oncology|January 12, 2012
Hematopoietic stem cell transplantation for chronic lymphocytic leukemiaDouglas E Gladstone, Ephraim Fuchs
Transplantation|April 13, 2004
Cryptococcus albidus infection in a patient undergoing autologous progenitor cell transplantRadhakrishnan Ramchandren, Douglas E Gladstone
Journal of Evaluation in Clinical Practice|July 14, 2005
Quality of life after high-dose cyclophosphamide in patients with severe autoimmune diseasesAnn A Prestrud, Douglas E Gladstone
British Journal of Haematology|December 6, 2017
The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximabChristopher D Gocke, Douglas E Gladstone
Transfusion|December 21, 2012
Maintaining hemostasis in acquired von Willebrand syndrome: a review of intravenous immunoglobulin and the importance of rituximab dose schedulingJennifer A Kanakry, Douglas E Gladstone
Hematology. American Society of Hematology. Education Program|December 10, 2017
HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunitiesDouglas E Gladstone, Maria P Bettinotti
Current Treatment Options in Oncology|July 18, 2025
Covalent and Non-Covalent BTK Inhibition in Chronic Lymphocytic Leukemia TreatmentPratik V Shah, Douglas E Gladstone
Circulation|September 21, 2020
ECMO Therapy for Cardiac LymphomaGeorge Leef, Douglas E Gladstone, Oscar Cingolani
Clinical Lymphoma, Myeloma & Leukemia|January 3, 2017
Change in IgHV Mutational Status of CLL Suggests Origin From Multiple ClonesAfaf Osman, Christopher D Gocke, Douglas E Gladstone
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Current Opinion in Oncology|December 21, 2010
High-dose chemotherapy and multiple sclerosisDaniel Harrison, Douglas E Gladstone
Current Opinion in Oncology|January 12, 2012
Hematopoietic stem cell transplantation for chronic lymphocytic leukemiaDouglas E Gladstone, Ephraim Fuchs
Transplantation|April 13, 2004
Cryptococcus albidus infection in a patient undergoing autologous progenitor cell transplantRadhakrishnan Ramchandren, Douglas E Gladstone
Journal of Evaluation in Clinical Practice|July 14, 2005
Quality of life after high-dose cyclophosphamide in patients with severe autoimmune diseasesAnn A Prestrud, Douglas E Gladstone
British Journal of Haematology|December 6, 2017
The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximabChristopher D Gocke, Douglas E Gladstone
Transfusion|December 21, 2012
Maintaining hemostasis in acquired von Willebrand syndrome: a review of intravenous immunoglobulin and the importance of rituximab dose schedulingJennifer A Kanakry, Douglas E Gladstone
Hematology. American Society of Hematology. Education Program|December 10, 2017
HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunitiesDouglas E Gladstone, Maria P Bettinotti
Current Treatment Options in Oncology|July 18, 2025
Covalent and Non-Covalent BTK Inhibition in Chronic Lymphocytic Leukemia TreatmentPratik V Shah, Douglas E Gladstone
Circulation|September 21, 2020
ECMO Therapy for Cardiac LymphomaGeorge Leef, Douglas E Gladstone, Oscar Cingolani
Clinical Lymphoma, Myeloma & Leukemia|January 3, 2017
Change in IgHV Mutational Status of CLL Suggests Origin From Multiple ClonesAfaf Osman, Christopher D Gocke, Douglas E Gladstone
Pageof 10